A class action suit has been filed against Aurobindo Pharma and Emcure Pharmaceuticals in a Florida court for allegedly concealing information about cancer-causing agent, N- nitrosodimethylamine (NDMA) presence in metformin medicine.
MSP Recovery Claims filed the petition on April 3 in U.S. District Court for the Southern District of Florida on behalf of similarly-situated healthcare insurers to recover payments unlawfully induced by the drug makers- Aurobindo Pharma, Aurolife Pharma, LLC and Heritage Pharmaceuticals LLC.
Metformin is the most prescribed oral pharmaceutical drug for patients with type-2 diabetes. The petition was based on tests done by Valisure, an online pharmacy.
Valisures